Pramirol SR 1.05mg Tablet (Pramipexole 1.05mg): Extended-Release Formulation for Parkinson’s Disease and Restless Legs Syndrome
The pramipexole that is found in the pharmaceutical product known as Pramirol SR 1.05mg Tablet is what makes it an effective medication. It is an extended-release formulation that was developed specifically for the treatment of restless legs syndrome (RLS) and Parkinson’s disease. This overview of Pramirol SR 1.05mg Tablet is meant to provide a comprehensive look at the medication, including its composition, mechanism of action, therapeutic indications, and potential benefits.
Composition and Formulation
Pramipexole is a dopamine agonist that acts selectively on dopamine receptors in the brain, and the active ingredient in Pramirol SR 1.05mg Tablet is this dopamine agonist. The tablet is made using a formulation known as extended-release, which allows for the active ingredient to be released in a manner that is both controlled and sustained over a longer period of time. Because of this, a single daily dose is all that is required to maintain consistent therapeutic effects throughout the day.
Mechanism of Action
Pramipexole, the active ingredient in Pramirol SR 1.05mg Tablet, functions as a dopamine agonist by stimulating dopamine receptors in the brain. This is how the tablet gets its name. It primarily focuses on the D2 and D3 receptors, imitating the action of the neurotransmitter dopamine, which plays a role in the control of movement and the regulation of motor activity. The symptoms of Parkinson’s disease and restless legs syndrome can be alleviated with the help of pramipexole, which works by increasing the activity of dopamine in the brain.
Related Product
Pramirol SR 3.15mg Tablet
Pramirol SR 0.52mg Tablet
Pramirol SR 1.05mg Tablet
Pramirol SR 2.1mg Tablet
Pramirol 1.5mg Tablet
Pramirol 0.125mg Tablet
Pramirol 0.25mg Tablet
Pramirol 0.5mg Tablet
Pramirol 1mg Tablet
Therapeutic Indications
The following conditions are the primary indications for the use of the Pramirol SR 1.05mg Tablet:
Parkinson’s disease: A progressive neurological disorder, Parkinson’s disease is characterised by motor symptoms such as tremors, rigidity, and bradykinesia. Pramirol SR 1.05mg Tablet is prescribed for the management of Parkinson’s disease. It assists in enhancing motor control and lessening the impact that these symptoms have on day-to-day activities.
Restless legs syndrome (RLS) is a condition that is characterised by an irresistible urge to move the legs, which is typically accompanied by uncomfortable sensations. Pramirol SR 1.05mg Tablet is also used in the treatment of restless legs syndrome. Pramipexole helps individuals with restless leg syndrome (RLS) get better sleep and feel better overall by easing the uncomfortable sensations they experience and cutting down on the number of times they move their legs.
Potential Benefits
Patients suffering from Parkinson’s disease and restless legs syndrome may experience a number of potential benefits if they take Pramirol SR 1.05mg Tablet. These benefits include the following:
- Pramirol SR 1.05mg Tablet provides a sustained release of pramipexole, which ensures consistent dopamine receptor stimulation throughout the day. This enables the medication to provide continuous symptom control. This helps to maintain optimal symptom control, particularly in Parkinson’s disease, and reduces motor fluctuations and “off” periods associated with immediate-release formulations. Parkinson’s disease is one of the diseases that can be affected by this.
- Patients do not need to take multiple doses throughout the day, so the once-daily dosing regimen of Pramirol SR 1.05mg Tablet makes it easier for them to adhere to their medication regimen. This results in improved adherence. This factor of convenience can improve treatment compliance, which in turn can lead to better overall therapeutic results.
- Pramirol SR 1.05mg Tablet helps to alleviate the uncomfortable sensations and urge to move that are associated with restless legs syndrome, which leads to an improvement in the quality of sleep. It does this by enhancing the quality of sleep and lowering the number of disruptions that occur during the night, which contributes to a more restful and revitalising experience while sleeping.
- Individualised dosing flexibility: Because Pramirol SR 1.05mg Tablet is offered in a range of strengths, individualised dosing can be accomplished by tailoring the medication’s dosage to the individual requirements of each patient. Because of this flexibility, medical professionals are able to modify the treatment regimen in accordance with the individual’s response to therapy and the severity of the symptoms being treated.
Side Effects
Like any medication, Pramirol SR 1.05mg Tablet may cause side effects in some individuals. Common side effects may include nausea, dizziness, headache, fatigue, constipation, and dry mouth. These side effects are usually mild and transient, resolving on their own as the body adjusts to the medication. However, if any side effects persist or worsen, it is important to inform the healthcare provider promptly.
In rare cases, Pramirol SR 1.05mg Tablet may cause more severe side effects that require immediate medical attention. These may include hallucinations, confusion, excessive daytime sleepiness, difficulty in controlling movements, or compulsive behaviors. It is crucial to seek medical help if any of these serious side effects occur.
Conclusion
Pramirol SR 1.05mg Tablet is an extended-release formulation designed to provide continuous symptom control in patients with Parkinson’s disease and restless legs syndrome. Its active ingredient is pramipexole, and it contains 1.05 milligrammes of pramipexole per tablet. It does this by performing the function of a dopamine agonist, which helps to alleviate motor symptoms, improve the quality of sleep, and enhance overall well-being. Pramirol SR 1.05mg Tablet should only be taken under the supervision and with a prescription from a qualified healthcare professional due to the fact that individual dosages and treatment regimens may vary. It is important to note this, as it is important to note that individual dosages and treatment regimens may vary.
